vimarsana.com

Latest Breaking News On - Pexis ag - Page 1 : vimarsana.com

Spexis provides business update and announces financial

Spexis provides business update and announces financial results for the first half of 2023.

United statesSwitzerland generalUnited kingdomHernan levettStephan feldhausOliver zerbeStephen jasperMaxim groupTrinity hall collegeUniversity of oxfordAmerican cancer societyBlavatnik family foundationEuropean research councilEuropean federation of medicinal chemistryUniversity of zurichEuropean innovative medicines initiative

Spexis announces USD $2 5 million capital commitment to

Ad hoc announcement pursuant to Art. 53 LR ALLSCHWIL, Switzerland, Aug. 14, 2023 (GLOBE NEWSWIRE) Spexis AG (SIX: SPEX), a clinical-stage.

Switzerland generalStephan feldhausHernan levettJeff wagerSwiss stock exchange spex swPexis agCystic fibrosisRespiratory disease

Spexis reports solid safety and pharmacokinetics results

Ad hoc announcement pursuant to Art. 53 LR Inhaled murepavadin shown to be well tolerated at all dose levels Program derived from Spexis’.

Switzerland generalHernan levettStephan feldhausJuergen froehlichEuropean innovative medicines initiativeChief medical officerSwiss stock exchange spex swPexis agCystic fibrosisOn cf bronchiectasisClinical dataPhase 1

Spexis announces promising pre-clinical data with

Balixafortide shown to have synergistic or additive effect with conventional or targeted therapies across all tested B-cell lymphomas ALLSCHWIL,.

Switzerland generalBrigitte keller laurie doyleFrancesco bertoniHernan levettStephan feldhausJuergen froehlichFosun pharmaRaimund gabrielMc servicesInstitute deputyInstitute of oncology research in bellinzonaOncology researchLymphoma genomicsInstitute deputy directorAdjunct professorSvizzera italiana

Investegate |Spexis AG Announcements | Spexis AG: Spexis to present at BioEquity Europe 2022

Investegate announcements from Spexis AG, Spexis to present at BioEquity Europe 2022

Rate fixInvestegate announcementsInvestegate company announcementsPexis agEgulatory news serviceEgulatory news service and regulatory

vimarsana © 2020. All Rights Reserved.